ARD Podcast

BMJ Group
ARD Podcast
Último episódio

25 episódios

  • ARD Podcast

    Use of imaging in large vessel vasculitis: EULAR 2023 update

    21/06/2024 | 31min
    Join our host Dr. Fabian Proft, ARD's Social Media Advisor, as he discusses the updated 2023 EULAR recommendations for imaging in large vessel vasculitis (LVV) with Professor Christian Dejaco and Dr. Milena Bond, the lead authors of the manuscript. This episode covers the latest evidence on ultrasound, MRI, CT, and FDG-PET for diagnosing and monitoring LVV.

    Key highlights include:

    Ultrasound as the first-line imaging test for giant cell arteritis.

    Preferred imaging modalities for Takayasu arteritis.

    Use of imaging for assessing vessel abnormalities and long-term monitoring.

    Insights into the research agenda for imaging in large vessel vasculitides.

    Tune in to learn how these updates aim to enhance patient care and stay informed on the latest developments in rheumatology imaging.

    Please subscribe to the ARD podcast on all podcast platforms, including Apple Podcast, Stitcher and Spotify. If you enjoy the show, feel free to leave us a comment or a review on the podcast iTunes page - https://podcasts.apple.com/gb/podcast/ard-podcast/id1171058059 .
  • ARD Podcast

    Managing Systemic Lupus Erythematosus: the latest EULAR recommendations

    22/04/2024 | 21min
    This podcast brings you the 2023 update on the EULAR recommendations for the management of systemic lupus erythematosus (SLE).

    ARD's Social Media Advisor, Professor Laura Andreoli, speaks to Professors Antonios Fanouriakis and Dimitrios Boumpas, both from the "Attikon" University Hospital, National and Kapodistrian University of Athens, Greece, two of the authors of the recommendations paper. Read it on the ARD website: https://ard.bmj.com/content/83/1/15.

    Please subscribe to the ARD podcast on all podcast platforms, including Apple Podcast, Stitcher and Spotify. If you enjoy the show, feel free to leave us a comment or a review on the podcast iTunes page - https://podcasts.apple.com/gb/podcast/ard-podcast/id1171058059 .
  • ARD Podcast

    A non-pharma approach in systemic lupus erythematosus and systemic sclerosis

    30/10/2023 | 18min
    In this podcast, we discuss the evidence-based EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus (SLE) and systemic sclerosis (SSc).
    ARD's Social Media Advisor, Professor Laura Andreoli, speaks to Professor Carina Boström and Professor Ioannis Parodis, both from the Karolinska Institutet and the Karolinska University Hospital, Stockholm, Sweden, about their recent paper. Read it on the ARD website: https://ard.bmj.com/content/early/2023/08/23/ard-2023-224416

    Please subscribe to the ARD podcast on all podcast platforms, including Apple Podcast, Google Podcasts, Stitcher and Spotify. If you enjoy the show, feel free to leave us a comment or a review on the podcast iTunes page -https://podcasts.apple.com/gb/podcast/ard-podcast/id1171058059 .
  • ARD Podcast

    Innate Lymphoid Cells link TGFb and fibrotic pathways in systemic sclerosis skin

    07/02/2022 | 21min
    In this podcast, Dr. Truchetet discusses her work on the role of innate lymphoid cells in the fibrotic processes in systemic sclerosis (SSc) patients. The group of Dr. Truchetet found that ILC2 are crucial mediators of skin fibrosis in SSc and that combined treatment of patients with TGFb inhibitors and IL-10 might be an attractive new therapeutic approach in SSc.
    Read the full paper on the ARD website: https://ard.bmj.com/content/80/12/1594
    Please subscribe to the ARD podcast on all podcast platforms, including Apple Podcast, Google Podcasts, Stitcher and Spotify. If you enjoy the show, feel free to leave us a comment or a review on the podcast iTunes page (https://podcasts.apple.com/gb/podcast/ard-podcast/id1171058059).
  • ARD Podcast

    Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases

    29/07/2021 | 20min
    In this podcast, we invite two authors from recent ARD papers dedicated to the efficacy of mRNA vaccines in patients with immunosuppressive therapies.
    Christophe Richez, Department of Rheumatology, University Medical Center, Bordeaux, France, and ARD's Social Media Advisor, interviews Bimba Hoyer, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Germany, and Rebecca H Haberman, Division of Rheumatology, University Grossman School of Medicine, New York, USA. They describe their works and offer their thoughts on the current situation in this area and the future.
    Related content:
    https://ard.bmj.com/content/early/2021/05/11/annrheumdis-2021-220272
    https://ard.bmj.com/content/early/2021/06/07/annrheumdis-2021-220597

Mais podcasts de Saúde e fitness

Sobre ARD Podcast

Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer-reviewed proceedings of international meetings are featured. ARD is the official journal of EULAR.
Site de podcast

Ouça ARD Podcast, Cartas de um Terapeuta e muitos outros podcasts de todo o mundo com o aplicativo o radio.net

Obtenha o aplicativo gratuito radio.net

  • Guardar rádios e podcasts favoritos
  • Transmissão via Wi-Fi ou Bluetooth
  • Carplay & Android Audo compatìvel
  • E ainda mais funções

ARD Podcast: Podcast do grupo

Informação legal
Aplicações
Social
v8.7.2 | © 2007-2026 radio.de GmbH
Generated: 3/6/2026 - 10:40:39 PM